Please Note: These all apply to the first
printings of the book; they have been corrected in subsequent printings as they
were discovered.
| Date |
Drug Monograph
& Version |
Error/Update |
| 11/20/06 |
Altrenogest Monograph
Desk p. 21 Pocket p. 30 |
Under Storage/Stability/Compatibility, add:
Altrenogest is reportedly very sensitive to light; dispense in light-resistant
containers. |
| 11/20/06 |
Bromides Monograph
Desk p. 95 Pocket p. 137 |
In Adverse
Effects/Warnings, first sentence, third paragraph; Sentence should read: "If the
patient cannot tolerate the gastrointestinal effects (vomiting) of potassium
bromide …" |
| 11/20/06 |
Carbenicillin Monograph
Pocket p. 165, 167 |
Fix running head
|
|
11/20/06 |
Clomipramine Monograph
Desk p. 188 Pocket p. 271 |
Add to the first paragraph in Contraindications/Precautions: “As they may contain high levels of
tyramine, avoid giving aged cheeses to animals receiving clomipramine. |
| 11/20/06 |
Desmopressin Monograph
Desk p. 225 Pocket p. 324 |
In Dosing Section add under
Doses - add: When doses listed
below use “drops” of the nasal solution they are referencing the 0.1 mg/ml
product and NOT the 1.5mg/ml product (Stimate®). Do not confuse the two. |
|
11/20/06 |
Fluoxetine Monograph
Desk p. 348 Pocket p. 500 |
Delete the dose
for dogs (“c”) referenced to Reisner and Houpt. There is some question as to
whether this dose is for dogs or cats. |
|
11/20/06 |
Leuprolide Monograph
Desk p. 452 Pocket p. 650 (change 649
and 650 to make added text fit on 650) |
In the Dose
section for Ferrets (“c”; Murray 2002): After the sentence “ The diluted form
appears to be remain active after being stored in the freezer for a year.” Add:
“(Note: The manufacturer states that the depot form is not to be frozen and no
studies are known that support the stability of the depot activity when frozen
and thawed—Plumb)” |
|
11/20/06 |
Melphalan Monograph
Desk
p.492 has not been changed in latest printing of desk
Pocket p 707
|
In the
Storage/Stability/Compatibility section: Change in first sentence from “… at
room temperature (15-30°C; 59-86°F).” to “in the refrigerator.” |
|
11/20/06 |
Meformin Monograph
Desk p 498
Pocket p. 716-717 (note:
only 716 needs to be changed as 717 is correct in the 1st printing)
|
In the Adverse
Effects/Warnings section.
Desk: Last sentence should
read: “Hypoglycemia would not be an expected adverse effect when metformin is
used as a single agent.”
Pocket version: Starting on
bottom of page 716 should read: “As the cause of death was undetermined,
metformin could not be ruled out as a causative factor. Hypoglycemia would not
be an expected adverse effect when metformin is used as a single agent.”
|
|
11/20/06 |
Phosphate Monograph
Desk
p. 635 Has not been changed in latest printing of desk
Pocket p. 913
|
Fix typo in last
paragraph under Human-Approved Products; Delete the extra “m” and spaces. |
|
11/20/06 |
Pyrantel Monogaph
Desk p 679
Pocket p. 976
|
Delete Whipworms
from the first dose for dogs. Pyrantel not effective for Whipworms. |
|
11/20/06 |
Tepoxalin Monograph
Desk p. 736
Pocket p. 1058
|
In the Overdosage/Acute
Toxicity section. The third sentence should read: “At necropsy, all dogs showed
gastric lesions.” Delete: “one dog” |
|
11/20/06 |
Appendix: Instructions for
Legally Importing Drugs for Compassionate Use
Desk p. 886
Pocket p. 1254
|
Toni Wooten’s
phone and fax numbers have changed; Phone 240-276-9220; FAX: 240-276-9241 |
|
11/20/06 |
Pocket Version Index
pp. 1301-1311
|
The index of this version (Pocket) lists
incorrect page numbers for items found on pages 751-1169.
For indexed items in this page range, subtract
one page from that listed to properly locate the item.
|
|
4/15/07 |
Desk p. 834
Pocket p. 1198 |
Change the concentration of compounded ophthalmic
tacrolimus from 0.1 – 0.3% to 0.01 – 0.03%. |
